List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 41 studies with search of: Carnitine AND NOT Acetyl-L-carnitine
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Evaluation of Cilostazol in Combination With L-Carnitine
Conditions: Peripheral Vascular Disease;   Intermittent Claudication;   Peripheral Arterial Disease
Interventions: Dietary Supplement: Levocarnitine tartrate;   Drug: cilostazol
2 Completed Combination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia Intermedia
Condition: β-Thalassemia Intermedia
Interventions: Drug: hydroxyurea;   Drug: L-carnitine and hydroxyurea;   Drug: hydroxyurea and magnesium chloride;   Drug: hydroxyurea,L-carnitine and magnesium chloride
3 Recruiting Carnitine Levels and Carnitine Supplementation in Type I Diabetes
Conditions: Diabetes Mellitus, Type I;   Hypoglycemia
Intervention: Drug: Carnitine (drug)
4 Completed Propionyl-L-Carnitine in Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Propionyl-L-Carnitine;   Drug: Placebo
5 Recruiting L-Carnitine as an Osmo-Metabolic Agent for Peritoneal Dialysis
Condition: End-Stage Renal Disease
Intervention: Drug: L-Carnitine
6 Not yet recruiting Oral Carnitine for Cramps in Pregnancy
Condition: Muscle Cramp
Interventions: Dietary Supplement: L-Carnitine;   Dietary Supplement: Placebo
7 Completed
Has Results 		L-Carnitine in Peritoneal Dialysis
Condition: End-Stage Renal Disease
Intervention: Drug: L-carnitine
8 Recruiting Effect of an L-carnitine-containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)
Conditions: End Stage Renal Disease;   Insulin Resistance
Interventions: Drug: PD solution;   Drug: PD solution containing L-carnitine
9 Recruiting Effect of an L-Carnitine-Containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)
Conditions: End Stage Renal Disease;   Diabetes
Interventions: Drug: PD Solution;   Drug: PD solution containing L-carnitine
10 Completed Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy
Condition: Spinal Muscular Atrophy
Intervention: Drug: Valproic Acid and Levocarnitine
11 Recruiting Effects of L-Carnitine on Postprandial Clearance of Triglyceride-Rich Lipoproteins in HIV Patients on HAART
Conditions: Hyperlipidemia;   HIV Infections
Interventions: Dietary Supplement: L-carnitine;   Other: placebo
12 Recruiting Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAART
Conditions: HIV Infections;   Hyperlipidemia;   Exercise
Intervention: Dietary Supplement: l-carnitine
13 Recruiting Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy
Condition: Heart Failure
Intervention: Drug: L-carnitine
14 Recruiting Early Administration of L-Carnitine in Hemodialysis Patients
Conditions: Patient Beginning Chronic Hemodialysis for Less Than 1 Month;   Treated With rHuerythropoietin
Intervention: Drug: L-Carnitine
15 Completed L-Carnitine to Treat Fatigue in AIDS Patients
Conditions: HIV Infections;   AIDS
Interventions: Drug: L-carnitine;   Other: Placebo
16 Recruiting Effects of Parenteral L-Carnitine Supplementation in Premature Neonates
Condition: Prematurity
Interventions: Drug: Parenteral L-carnitine supplementation;   Drug: Parenteral supplementation with sterile water
17 Recruiting Evaluation of the Effects of L-Carnitine Injection in Patients Undergoing Hemodialysis
Conditions: Cardiac Complications;   Signs and Symptoms;   Muscle Weakness;   Anemia;   Hypotension
Intervention: Drug: L-Carnitine Injection
18 Active, not recruiting Lactate Metabolism Study in HIV Infected Persons
Conditions: HIV Infections;   AIDS;   Lactic Acidosis;   Lipodystrophy
Intervention: Drug: cofactor supplementation (thiamine, riboflavin, L-carnitine)
19 Completed Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)
Conditions: Peripheral Vascular Diseases;   Intermittent Claudication
Intervention: Drug: Propionyl-L-Carnitine
20 Active, not recruiting L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer
Conditions: Breast Cancer;   Chemotherapeutic Agent Toxicity;   Neurotoxicity
Interventions: Dietary Supplement: L-carnitine L-tartrate;   Other: placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services